Disparities in screening, diagnosis, and treatment of diabetes mellitus among people with HIV at a large southeastern academic health center

Background People with HIV can survive decades on antiretroviral therapy (ART), but an increasing burden of metabolic disease, including diabetes mellitus (DM), threatens these gains. Prior studies found race and sex disparities in HIV treatment outcomes, but data on comorbid conditions remains scarce. We assessed whether disparities by race, sex, body mass index (BMI), and other factors existed in DM screening, incidence, and treatment outcomes in a large HIV care center in the southeastern US.